Skip to navigation Skip to main content

Cabozantinib (Cabometyx)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow examines cabozantinib (Cabometyx), indicated for the treatment of patients with advanced renal cell carcinoma (RCC) who have received prior anti-angiogenic therapy.

Topics:

Drug Information Hepatocellular Carcinoma Renal Cell Carcinoma Slideshows Stat Consult
  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More